In a colitis model, mesenteric B cells were capable of reducing CD4+ T cell-dependent colon inflammation [25] and mesenteric CD23hi B cells of H. polygyrus-infected mice were capable of inhibiting inflammation both in an EAE model and in an HDM-specific AAI model via an unknown mechanism [26]. The gene discussed is CD4; the disease is digestive system cancer.